|
RLIM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.42369999976E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.37650000473644E-08 |
| Normal-vs-Stage2 |
8.876200E-02 |
| Normal-vs-Stage3 |
4.693500E-02 |
| Normal-vs-Stage4 |
1.552430E-02 |
| Stage1-vs-Stage2 |
3.271400E-01 |
| Stage1-vs-Stage3 |
6.207800E-02 |
| Stage1-vs-Stage4 |
5.860800E-01 |
| Stage2-vs-Stage3 |
8.527000E-01 |
| Stage2-vs-Stage4 |
7.606600E-01 |
| Stage3-vs-Stage4 |
5.981800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.06989999987861E-07 |
| Normal-vs-AfricanAmerican |
2.219600E-04 |
| Normal-vs-Asian |
2.044300E-03 |
| Caucasian-vs-AfricanAmerican |
6.960400E-01 |
| Caucasian-vs-Asian |
5.561400E-01 |
| AfricanAmerican-vs-Asian |
5.141800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52360002392271E-09 |
| Normal-vs-Female |
2.096600E-01 |
| Male-vs-Female |
1.85547000000064E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.957200E-04 |
| Normal-vs-Extreme_Weight |
1.25300000375361E-08 |
| Normal-vs-Obese |
1.243680E-02 |
| Normal-vs-Extreme_Obese |
8.27180000000372E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.603020E-01 |
| Normal_Weight-vs-Obese |
2.331400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.745800E-01 |
| Extreme_Weight-vs-Obese |
7.023700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.484200E-01 |
| Obese-vs-Extreme_Obese |
3.928000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.832000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.395200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.89599999536705E-08 |
| Normal-vs-Age(81-100Yrs) |
3.043300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.276000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.768300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.298210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.492060E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.215000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.871000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.57140000012213E-07 |
| Normal-VS-Type2 PRCC |
3.6543E-05 |
| Normal-VS-KIRP CIMP |
7.394600E-01 |
| Normal-VS-Unclassified PRCC |
2.269600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.074800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.972100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.790100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.102160E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.205800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.168380E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62839999765063E-08 |
| Normal-vs-N1 |
4.574400E-01 |
| Normal-vs-N2 |
2.274200E-01 |
| N0-vs-N1 |
1.295650E-02 |
| N0-vs-N2 |
1.799750E-01 |
| N1-vs-N2 |
7.370800E-01 |
|
|
